Cymabay Therapeu
Biotechnology
Healthcare
CBAY
102 B shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
23.45
52 week high
24.47
high
23.87
52 week low
3.93
low
23.07
growth
264.21 %
previous Close
23.62
P/E ratio
market cap
1.31 B
div yield
0
net incoming
-808.00 K
97.70 %
net profit margin
-2.61 %
-2.00 %
operating incoming
-99.00 K
99.63 %
net change in cash
3.35 M
-91.38 %
cash on hand
35.48 M
-40.01 %
top